Tel Mond, Center District, Israel
A seasoned investor and strategist specializing in M&A, business development, and go-to-market execution in technology and life sciences. Passionate about bridging innovation with market adoption to accelerate growth. Extensive experience in international business development, deal-making, sales, marketing, strategic planning and fundraising. Proven record of leading both public and private enterprises, successfully guided complex organizations while driving sustainable growth and value creation. Cross-industry insights and operational expertise. Recognized for building and leading high-performance sales and marketing networks across the U.S., Europe, Asia, Australia and Africa .
IJW & Co. a boutique investment bank headquartered in Montreal with offices in Toronto and Miami, specializing in M&A advisory and strategic finance for technology and consumer-sector companies globally. Over almost two decades built a reputation for trusted partnerships, rigorous analysis and creating value through successful cross-border transactions.
NUTEK develops an AI-powered, handheld hyperspectral imaging scanner that enables real-time detection of residual cancerous tissue during surgery. Its technology transforms tumor removal from subjective estimation to objective, data-driven precision, reducing re-operations and improving patient outcomes. Backed by a multidisciplinary leadership team and proven clinical validation, NUTEK is positioned to disrupt the multi-billion-dollar guided surgery market.
Business Development & Go To Market Expert - Strategy , Strategic Partners Engagement, Commercial , Sales , Fund Raising
Diagnostic company focusing on the development and commercialization of cancer-related diagnostics, including early detection of disease, genetic risk and optimization of treatment modalities (personalized medicine) Under my leadership the company developed and launched novel oncology early detection technologies
Medical Device Company (Acquired by Meridian Bioscience Inc., Nasdaq: VIVO) . Led the company from pre-commercial stage to a fully operational global commercial organization, pioneering innovative breath testing solutions for GI and liver disorders. Spearheaded the U.S. market entry and expansion, growing the customer base from zero to 250 within two years post-FDA approval and manufacturing scale-up. Built and led a world-class internal sales team and established a robust distribution network, securing agreements with top-tier Fortune 500 distributors: McKesson, Henry Schein, and PSS. Achieved complete market dominance domestically, capturing 100% market share in the local market within one year; doubled sales in year two. Successfully penetrated major international markets, including Japan, Russia, Italy, Benelux, and Latin America, driving sustained global revenue growth. Orchestrated strategic partnerships and executed multi-million-dollar contracts with global pharmaceutical companies. Secured $30 million in financing to fuel R&D, global expansion, and commercialization efforts, supporting long-term growth and value creation.